Skip to content

Accounts Payable at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$4.23B+5.8%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$10.46B+9.6%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$773M+62.7%
LBR
LB Pharmaceuticals Inc Common StockLBRX
$7.12M
MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
$16.66M-17.9%
Alto Neuroscience logo
Alto NeuroscienceANRO
$3.37M+143%

Other financials

Income statement

See full
Operating income-$64.5M-174%
Net income-$60.7M-172%
EPS (diluted)-$1.34+95.4%

Balance sheet

See full
Cash & equivalents$55.7M
Total debt$5.6M
Total equity$399.8M+285%
Total assets$418.8M

Cash flow

See full
Operating cash flow-$51.2M-100%
CapEx$24.0K
Free cash flow-$51.2M

Valuation

See full
Market cap$1.39B+100%
Enterprise value$1.34B

Returns & leverage

See full
Return on equity-216.8%
Debt / equity
Current ratio22.9×

Where this comes from

Reported directly by MapLight Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.

The official record: MapLight Therapeutics, Inc. ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about MapLight Therapeutics, Inc. 's accounts payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MapLight Therapeutics, Inc. 's accounts payable?
MapLight Therapeutics, Inc. (MPLT) reported accounts payable of $3.19M in Q1 2026.
How has MapLight Therapeutics, Inc. 's accounts payable changed year-over-year?
MapLight Therapeutics, Inc. 's accounts payable increased by 403.6% year-over-year, from -$1.05M to $3.19M.
What does accounts payable mean?
Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.